Behavioral studies have suggested a key role for the cannabinoid system in the modulation of conditioned fear memory. Likewise, much of the literature has revealed that the serotonergic system affects Pavlovian fear conditioning and extinction. A high level of functional overlap between the serotonin and cannabinoid systems has also been reported. To clarify the interaction between the hippocampal serotonin (5-HT4) receptor and the cannabinoid CB1 receptor in the acquisition of fear memory, the effects of 5-HT4 agents, arachidonylcyclopropylamide (ACPA; CB1 receptor agonist), and the combined use of these drugs on fear learning were studied in a fear conditioning task in adult male NMRI mice. Pre-training intraperitoneal administration of ACPA (0.1 mg/kg) decreased the percentage of freezing time in both context- and tone-dependent fear conditions, suggesting impairment of the acquisition of fear memory. Pre-training, intra-hippocampal (CA1) microinjection of RS67333, a 5-HT4 receptor agonist, at doses of 0.1 and 0.2 or 0.2 µg/mouse impaired contextual and tone fear memory, respectively. A subthreshold dose of RS67333 (0.005 µg/mouse) did not alter the ACPA response in either condition. Moreover, intra-CA1 microinjection of RS23597 as a 5-HT4 receptor antagonist did not alter context-dependent fear memory acquisition, but it did impair tone-dependent fear memory acquisition. However, a subthreshold dose of the RS23597 (0.01 µg/mouse) potentiated ACPA-induced fear memory impairment in both conditions. Therefore, we suggest that the blockade of hippocampal 5-HT4 serotonergic system modulates cannabinoid signaling induced by the activation of CB1 receptors in conditioned fear.
AbushHAkiravI (2010) Cannabinoids modulate hippocampal memory and plasticity. Hippocampus20: 1126–1138.
2.
AndradeRChaputY (1991) 5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. J Pharmacol Exp Ther257: 930–937.
3.
ArenosJDMustyREBucciDJ (2006) Blockade of cannabinoid CB1 receptors alters contextual learning and memory. Eur J Pharmacol539: 177–183.
4.
BarnesNMSharpT (1999) A review of central 5-HT receptors and their function. Neuropharmacology38: 1083–1152.
5.
BlanchardRJBlanchardDC (1969) Crouching as an index of fear. J Comp Physiol Psychol67: 370–375.
BockaertJSebbenMDumuisA (1990) Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives. Mol Pharmacol37: 408–411.
9.
BraidaDLimontaVMalabarbaL. (2007) 5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague–Dawley rats. Eur J Pharmacol555: 156–163.
10.
CheginiHRNasehiMZarrindastMR (2014) Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice. Behav Brain Res261: 114–126.
11.
ConsoloSArnaboldiSGiorgiS. (1994) 5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. Neuroreport5: 1230–1232.
12.
De Oliveira AlvaresLDe OliveiraLFCamboimC. (2005) Amnestic effect of intrahippocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats. Neurobiol Learn Mem83: 119–124.
13.
De PetrocellisLCascioMGDi MarzoV (2004) The endocannabinoid system: a general view and latest additions. Br J Pharmacol141: 765–774.
14.
DonzisEJRennakerRLThompsonLT (2013) Fear conditioning alters neuron-specific hippocampal place field stability via the basolateral amygdala. Brain Res1525: 16–25.
15.
DumuisABouhelalRSebbenM. (1988) A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol34: 880–887.
16.
EgashiraNMatsudaTKoushiE. (2006) Involvement of 5-hydroxytryptamine1a receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice. Eur J Pharmacol550: 117–122.
17.
EgashiraNMishimaKKatsurabayashiS. (2002) Involvement of 5-hydroxytryptamine neuronal system in Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory. Eur J Pharmacol445: 221–229.
18.
Ganon-ElazarEAkiravI (2009) Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J Neurosci29: 11078–11088.
19.
GhiasvandMRezayofAAhmadiS. (2011) β1-noradrenergic system of the central amygdala is involved in state-dependent memory induced by a cannabinoid agonist, WIN55,212-2, in rat. Behav Brain Res225: 1–6.
20.
GiffordANAshbyCRJr (1996) Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716a. J Pharmacol Exp Ther277: 1431–1436.
21.
Haj-DahmaneSShenRY (2011) Modulation of the serotonin system by endocannabinoid signaling. Neuropharmacology61: 414–420.
22.
HashimotodaniYOhno-ShosakuTKanoM (2007) Endocannabinoids and synaptic function in the CNS. Neuroscientist13: 127–137.
23.
HerkenhamMLynnABLittleMD. (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A87: 1932–1936.
24.
HoyerDHannonJPMartinGR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav71: 533–554.
25.
KatonaIRanczEAAcsadyL. (2001) Distribution of Cb1 cannabinoid receptors in the amygdala and their role in the control of gabaergic transmission. J Neurosci21: 9506–9518.
26.
KimDThayerSA (2001) Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. J Neurosci21: RC146.
27.
KoganezawaNTaguchiATominagaT. (2008) Significance of the deep layers of entorhinal cortex for transfer of both perirhinal and amygdala inputs to the hippocampus. Neurosci Res61: 172–181.
28.
LestingJGeigerMNarayananRT. (2011) Impaired extinction of fear and maintained amygdala–hippocampal theta synchrony in a mouse model of temporal lobe epilepsy. Epilepsia52: 337–346.
29.
LevalletGHotteMBoulouardM. (2009) Increased particulate phosphodiesterase 4 in the prefrontal cortex supports 5-HT4 receptor-induced improvement of object recognition memory in the rat. Psychopharmacology (Berl)202: 125–139.
30.
MaloneDTTaylorDA (2001) Involvement of somatodendritic 5-HT(1a) receptors in Delta(9)-tetrahydrocannabinol-induced hypothermia in the rat. Pharmacol Biochem Behav69: 595–601.
31.
Manuel-ApolinarLRochaLPascoeD. (2005) Modifications of 5-HT4 receptor expression in rat brain during memory consolidation. Brain Res1042: 73–81.
32.
MarchettiEChaillanFADumuisA. (2004) Modulation of memory processes and cellular excitability in the dentate gyrus of freely moving rats by a 5-HT4 receptors partial agonist, and an antagonist. Neuropharmacology47: 1021–1035.
33.
MarcoEMPerez-AlvarezLBorcelE. (2004) Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats. Behav Pharmacol15: 21–27.
34.
MarsicanoGLutzB (2006) Neuromodulatory functions of the endocannabinoid system. J Endocrinol Invest29: 27–46.
35.
MarsicanoGWotjakCTAzadSC. (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature418: 530–534.
36.
MenesesA (1999) 5-HT system and cognition. Neurosci Biobehav Rev23: 1111–1125.
37.
MenesesA (2015) The Role of 5-HT Systems on Memory and Dysfunctional Memory. Oxford: Academic Press.
38.
MoitaMARosisSZhouY. (2003) Hippocampal place cells acquire location-specific responses to the conditioned stimulus during auditory fear conditioning. Neuron37: 485–497.
39.
Murillo-RodriguezEMillan-AldacoDDi MarzoV. (2008) The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. Neuroscience157: 1–11.
40.
NarayananRTSeidenbecherTKlugeC. (2007) Dissociated theta phase synchronization in amygdalo- hippocampal circuits during various stages of fear memory. Eur J Neurosci25: 1823–1831.
41.
NasehiMAmin-YavariSEbrahimi-GhiriM. (2015a) The dual effect of CA1 NMDA receptor modulation on ACPA-induced amnesia in step-down passive avoidance learning task. Eur Neuropsychopharmacol25: 557–565.
42.
NasehiMDavoudiKEbrahimi-GhiriM. (2016) Interplay between serotonin and cannabinoid function in the amygdala in fear conditioning. Brain Res1636: 142–151.
43.
NasehiMHajianMEbrahimi-GhiriM. (2015b) Role of the basolateral amygdala dopamine receptors in arachidonylcyclopropylamide-induced fear learning deficits. Psychopharmacology (Berl)233: 213–224.
44.
NasehiMKafiFKhakpaiF. (2015c) Involvement of the serotonergic system of the ventral hippocampus (CA3) on amnesia induced by ACPA in mice. Behav Brain Res286: 356–363.
45.
NasehiMSharaf-DolgariEEbrahimi-GhiriM. (2015d) The hippocampal NMDA receptors may be involved in acquisition, but not expression of ACPA-induced place preference. Prog Neuropsychopharmacol Biol Psychiatry63: 83–90.
46.
NasehiMTabatabaieMKhakpaiF. (2015e) The effects of CA1 5HT4 receptors in MK801-induced amnesia and hyperlocomotion. Neurosci Lett587: 73–78.
47.
PamplonaFATakahashiRN (2006) WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors. Neurosci Lett397: 88–92.
48.
PareDCollinsDR (2000) Neuronal correlates of fear in the lateral amygdala: multiple extracellular recordings in conscious cats. J Neurosci20: 2701–2710.
49.
PareDCollinsDRPelletierJG (2002) Amygdala oscillations and the consolidation of emotional memories. Trends Cogn Sci6: 306–314.
50.
PaxinosGFranklinKBJ (2001) The Mouse Brain in Stereotaxic Coordinates. 2nd ed.Oxford: Academic Press.
51.
PelletierJGPareD (2004) Role of amygdala oscillations in the consolidation of emotional memories. Biol Psychiatry55: 559–562.
52.
PhillipsRGLedouxJE (1992) Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci106: 274–285.
53.
PiomelliD (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci4: 873–884.
54.
ReichCGMohammadiMHAlgerBE (2008) Endocannabinoid modulation of fear responses: learning and state-dependent performance effects. J Psychopharmacol22: 769–777.
55.
ReynoldsGPMasonSLMeldrumA. (1995) 5-hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. Br J Pharmacol114: 993–998.
56.
RoychowdhurySHaasHAndersonEG (1994) 5-HT1A and 5-HT4 receptor colocalization on hippocampal pyramidal cells. Neuropharmacology33: 551–557.
57.
SchlickerETimmJZentnerJ. (1997) Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn Schmiedebergs Arch Pharmacol356: 583–589.
58.
ShenFSmithJAChangR. (2011) 5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: a pharmacodynamic and pharmacokinetic assessment. Neuropharmacology61: 69–79.
59.
ShojiHTakaoKHattoriS. (2014) Contextual and cued fear conditioning test using a video analyzing system in mice. J Vis Exp. DOI: 10.3791/50871.
60.
SuzukiAJosselynSAFranklandPW. (2004) Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci24: 4787–4795.
61.
VarvelSAAnumEALichtmanAH (2005) Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice. Psychopharmacology (Berl)179: 863–872.
62.
WangSJ (2003) Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes. Eur J Pharmacol469: 47–55.
63.
WardSJLefeverTWJacksonC. (2008) Effects of a cannabinoid1 receptor antagonist and serotonin2c receptor agonist alone and in combination on motivation for palatable food: a dose–addition analysis study in mice. J Pharmacol Exp Ther325: 567–576.
64.
YokoyamaMSuzukiESatoT. (2005) Amygdalic levels of dopamine and serotonin rise upon exposure to conditioned fear stress without elevation of glutamate. Neurosci Lett379: 37–41.
